公司概覽
業務類別 Biotechnology
業務概覽 Ascendis Pharma AS is a biopharmaceutical company that applies its TransCon technology platform to make a meaningful difference for patients. The firm's product pipeline includes Endocrinology and Oncology, which includes TransCon PTH, TransCon CNP, and others. It operates in the United States, Europe, and the rest of the world and derives the majority of its revenue from the United States.
公司地址 Tuborg Boulevard 12, Hellerup, DNK, 2900
電話號碼 +45 70222244
傳真號碼 --
公司網頁 https://www.ascendispharma.com
員工數量 1189
 
公司高管 / 董事會成員
公司高管
高管 職務 年薪 更新日期
Ms. Aimee Shu Executive Vice President and Chief Medical Officer -- 11/02/2026
Dr. Jethro Ekuta, D.V.M.,PhD Chief Regulatory and Safety Officer -- 11/02/2026
Mr. Mads Bodenhoff Senior Vice President, Head of Finance and Principal Accounting Officer -- 11/02/2026
Mr. Jay Donovan Wu Executive Vice President and U.S. President -- 11/02/2026
Ms. Sherrie Glass, M.P.A. Chief Business Officer -- 11/02/2026
Mr. Michael Wolff Jensen, L.L.M. Executive Vice President and Chief Legal Officer -- 11/02/2026
Mr. Jan Moller Mikkelsen President, Chief Executive Officer and Director -- 11/02/2026
Ms. Lotte Sonderbjerg Executive Vice President and Chief Administrative Officer -- 11/02/2026
Mr. Flemming Steen Jensen Executive Vice President, Product Supply and Quality -- 11/02/2026
Dr. Kennett Sprogoe, PhD Executive Vice President and Head of Innovation and Research -- 11/02/2026
Mr. Scott T Smith Executive Vice President and Chief Financial Officer -- 11/02/2026
Dr. Stina Singel, M.D.,PhD Executive Vice President and Head of Clinical Development, Oncology -- 11/02/2026
 
董事會成員
董事會 職務 更新日期
Dr. Albert Cha, M.D.,PhD Chairman of the Board 11/02/2026
Mr. Jan Moller Mikkelsen President, Chief Executive Officer and Director 11/02/2026
Ms. Lisa Bright Independent Director 11/02/2026
Mr. William Carl Fairey, Jr Independent Director 11/02/2026
Mr. Lars Holtug Independent Director 11/02/2026
Ms. Siham Imani Independent Director 11/02/2026
 
所屬ETF (更新日期: 07/03/2026 02:53)
代號 名稱 佔比% 持有日期
IBBiShares Biotechnology ETF0.56%28/02/2026
TCAFT. Rowe Price Capital Apprec Eq ETF0.49%28/02/2026
CGGRCapital Group Growth ETF0.22%31/01/2026
FDGAmerican Century Foc Dynmc Gr ETF0.08%31/12/2025
SPDWState Street® SPDR® Ptf Dev Wld exUS ETF0.06%27/02/2026
MSSMMorgan Stanley Pathway Sm-Md Cp Eq ETF0.05%28/02/2026
QQQJInvesco NASDAQ Next Gen 100 ETF0.04%27/02/2026
ASGLiberty All-Star Growth0.04%31/12/2025
HQHabrdn Healthcare Investors0.04%31/01/2026
MEDIHarbor Health Care ETF0.03%28/02/2026
PFUTPutnam Sustainable Future ETF0.03%20/02/2026
ONEQFidelity Nasdaq Composite ETF0.02%27/02/2026
HQLabrdn Life Sciences Investors0.02%31/01/2026
ILDRFirst Trust Innovation Leaders ETF0.02%26/02/2026
TMSLT. Rowe Price Small-Mid Cap ETF0.02%28/02/2026
FFOGFranklin Focused Growth ETF0.02%28/02/2026
AADRAdvisorShares Dorsey Wright ADR ETF0.01%27/02/2026
BMEZBlackRock Health Sciences Term Trust0.01%31/12/2025
FMEDFidelity Disruptive Medicine ETF0.01%27/02/2026
IBBQInvesco Nasdaq Biotechnology ETF0.01%27/02/2026
 1    2    3  
 

Copyright © 2026 ET Net Limited.
All rights reserved. Use of this site signifies your agreement to the terms of use.
DISCLAIMER: ET Net Limited and Third Party Information Providers endeavour to ensure the accuracy and reliability of the information provided, but do not guarantee its accuracy and reliability and accept no liability (whether in tort or contract or otherwise) for any loss or damage arising from any inaccuracies or omissions.